JESDUVROQ
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JESDUVROQ, covering 2023-02-01 to 2023-12-13. Get the full timeline:
Most recent: EMA Application withdrawn: Jesduvroq (daprodustat) — GlaxoSmithKline Trading Services Limited